Pfizer launches biosimilars to Roche's 'big three' cancer dr...

Pfizer has announced the launch of its competitors to Roche’s ‘big three’ cancer drugs in the US, at a “substantially discounted price” compared with the originators.

New Dates Released for J+D's Pharma Forecasting Training

J+D releases new forecasting training dates

Nine pharma trends for 2020

Sarah Rickwood looks back at how pharma changed over the last decade and what this might mean for the industry in 2020.

The 4 biggest pharma market access stories of 2019

What events have defined the market access landscape in 2019, and what trends will shape 2020? We dive into the pharmaphorum archives to find out.

Nine for 2019: how did we do on our predictions, and what do...

Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead.

US eyes faster launch for biosimilars in North American trad...